Glycerin
- Product NDC
- 52316-725
- 11-digit product format
- 523160725
- Labeler code
- 52316
- Product ID
- 52316-725_41e9f956-2af0-7c10-e063-6394a90a4a23
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Glycerin
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- DSC Laboratories Inc.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-04-17
- Substance
- GLYCERIN
- Active strength
- 2.1 g/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glycerin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLYCERIN | 2.1 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | PDC6A3C0OX |
| Rxcui | 583084 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52316-725-25 | Glycerin | 25 in 1 JAR | SUPPOSITORY | 25 | | 8 |
| 52316-725-50 | Glycerin | 50 in 1 JAR | SUPPOSITORY | 50 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52316-725 | GLYCERIN SUPPOSITORY [DSC LABORATORIES INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20241215_a381838b-d1ae-11c5-e053-2a95a90a7bcb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52316-725-25 | 52316072525 | 25 in 1 JAR | | | | | | Historical |
| 52316-725-50 | 52316072550 | 50 SUPPOSITORY in 1 JAR (52316-725-50) | 50 suppository | 2020-04-17 | 0000-00-00 | No | No | Current |